MedPath

Comparative study of the Effects of Emla Cream and Diclofenac Gel on Chemo Port Pain in patients Referring to Oncology wards in Zahedan University of Medical Sciences Affiliated Hospitals

Phase 2
Recruiting
Conditions
cancer.
Neoplasms
Registration Number
IRCT2017080635520N1
Lead Sponsor
Vice chancellor for research Zahedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Inclination to participate in research; Having verbal, subjective, vision ability; At present there is no acute psychiatric disorder; There is no history of favism, congenital idiopathic hemoglobin, liver disease, skin allergy, skin dermatitis; no treatment with sulfonamides, nitrates Phenobarbital, non-diabetes, non-addiction, non-use of housing in the last 24 hours.
Exit criteria:
The wound of the port's location during the intervention; Infection and secretion at the port site during the intervention; Failure to follow the first action.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Emlacream. Timepoint: During the intervention. Method of measurement: Geram.;Diclofenac gel. Timepoint: During the intervention. Method of measurement: Geram.;Vitamin(A+D). Timepoint: During the intervention. Method of measurement: Geram.
Secondary Outcome Measures
NameTimeMethod
Sex. Timepoint: During the intervention. Method of measurement: Patient case.;Duration under chemotherapy. Timepoint: During the intervention. Method of measurement: Day.;Age. Timepoint: During the intervention. Method of measurement: Years.;Severity of pain. Timepoint: During the intervention. Method of measurement: Vas.;Duration of port usage. Timepoint: During the intervention. Method of measurement: Day.
© Copyright 2025. All Rights Reserved by MedPath